As President of Biomedical Research, Dr. Marshall leads approximately 5,300 scientists and other associates across six research sites dedicated to the discovery of high-value medicines for patients. She collaborates with experts across the pipeline—from R&D to manufacturing and commercial development—to ensure Biomedical Research’s technological and scientific breakthroughs translate into therapies that address the world’s greatest disease burdens.

Prior to taking up her current role in November 2022, Dr. Marshall served as senior vice president and global head of discovery sciences, preclinical development and translational medicine at MSD (Merck & Co in the US). Prior to that, she was a founder and chief scientific officer of Heptares Therapeutics, a UK-based biotechnology company focused on structure-based drug design. Earlier in her career, Dr. Marshall was director of molecular pharmacology at Millennium Pharmaceuticals and spent 10 years at GSK, holding senior positions in molecular pharmacology and neuroscience.

Dr. Marshall holds a bachelor’s degree in biochemistry from University of Bath and a doctorate in neuroscience from the University of Cambridge, both in the UK. She was the recipient of the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship Award, the 2015 RSC Malcolm Campbell Award for Chemistry, and the Vane Medal from the British Pharmacological Society. She is also a fellow of the Royal Society and the Academy of Medical Sciences, and an honorary fellow of both the British Pharmacological Society and the Royal Society of Chemistry.